702675-42-1 Usage
Uses
Used in Pharmaceutical Industry:
N-(3-(5-Bromo-4-(3-(thiophene-2-carboxamido)propylamino)pyrimidin-2-ylamino)phenyl)pyrrolidine-1-carboxamide is used as a potential pharmaceutical agent for [application reason]. Its complex structure and functional groups may contribute to its activity against specific biological targets or diseases, making it a candidate for drug development.
Used in Agrochemical Industry:
In the agrochemical sector, N-(3-(5-Bromo-4-(3-(thiophene-2-carboxamido)propylamino)pyrimidin-2-ylamino)phenyl)pyrrolidine-1-carboxamide is used as a potential agrochemical compound for [application reason]. Its properties might be harnessed to address challenges in agriculture, such as pest control or crop protection.
Used in Materials Science:
N-(3-(5-Bromo-4-(3-(thiophene-2-carboxamido)propylamino)pyrimidin-2-ylamino)phenyl)pyrrolidine-1-carboxamide is utilized in materials science as a component in the development of new materials with [specific properties] for [application reason]. Its unique molecular structure could offer novel properties that are beneficial in creating advanced materials for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 702675-42-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,2,6,7 and 5 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 702675-42:
(8*7)+(7*0)+(6*2)+(5*6)+(4*7)+(3*5)+(2*4)+(1*2)=151
151 % 10 = 1
So 702675-42-1 is a valid CAS Registry Number.
InChI:InChI=1/C23H26BrN7O2S/c24-18-15-27-22(30-20(18)25-9-5-10-26-21(32)19-8-4-13-34-19)28-16-6-3-7-17(14-16)29-23(33)31-11-1-2-12-31/h3-4,6-8,13-15H,1-2,5,9-12H2,(H,26,32)(H,29,33)(H2,25,27,28,30)
702675-42-1Relevant articles and documents
Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKε kinases
McIver, Edward G.,Bryans, Justin,Birchall, Kristian,Chugh, Jasveen,Drake, Thomas,Lewis, Stephen J.,Osborne, Joanne,Smiljanic-Hurley, Ela,Tsang, William,Kamal, Ahmad,Levy, Alison,Newman, Michelle,Taylor, Debra,Arthur, J. Simon C.,Clark, Kristopher,Cohen, Philip
, p. 7169 - 7173,5 (2012/12/12)
The design, synthesis and structure-activity relationships of a novel series of 2,4-diamino-5-cyclopropyl pyrimidines is described. Starting from BX795, originally reported to be a potent inhibitor of PDK1, we have developed compounds with improved selectivity and drug-like properties. These compounds have been evaluated in a range of cellular and in vivo assays, enabling us to probe the putative role of the TBK1/IKKε pathway in inflammatory diseases.
CHK-, PDK- AND AKT-INHIBITORY PYRIMIDINES, THEIR PRODUCTION AND USE AS PHARMACEUTICAL AGENTS
-
Page 158; 228, (2008/06/13)
This invention relates to pyrimidine derivatives of general formula (I) as inhibitors of kinases, their production as well as their use as medications for treating various diseases.